Filing Flows › cbdMD (YCBD) › Q2 FY26 › vs Q2 FY25
cbdMD (YCBD) Q2 FY26 vs Q2 FY25 (year over year)
cbdMD's revenue rose $891K (+19%) from $4.7M in Q2 FY25 to $5.6M in Q2 FY26.
cbdMD, Q2 FY26: revenue $5.6M (+19% year over year), operating margin -14.2%, net loss $798K, operating cash flow −$722K. The chart draws each line against Q2 FY25, the increases inside each band.
Every line
| Line | Q2 FY26 | Q2 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $5.6M | $4.7M | $891K | +19% |
| Net loss | $798K | $481K | $317K | +66% |
| Costs & expenses | $6.4M | $5.2M | $1.2M | +23% |
| Operating costs | $6.4M | $5.2M | $1.2M | +23% |
| Cost of revenue | $2.4M | $1.8M | $593K | +33% |
| Operating expenses | $4.1M | $3.4M | $613K | +18% |
| Operating cash sources | $974K | $475K | $499K | +105% |
| Depreciation & amortization | $252K | $286K | −$34K | -12% |
| Cash used in operations | $722K | $189K | $533K | +281% |
| Net loss absorbed | $798K | $481K | $317K | +66% |
| Working capital & other | $176K | −$5K | $181K | — |
Questions
How much did cbdMD's revenue grow year over year in Q2 FY26?
cbdMD's revenue rose $891K (+19%) from $4.7M in Q2 FY25 to $5.6M in Q2 FY26.